Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PURINETHOL TEVA CANADA LIMITED Resolved 50MG Updated Report 2025-12-06 231946
SEROQUEL XR CHEPLAPHARM ARZNEIMITTEL GMBH Resolved 200MG Updated Report 2025-12-06 263832
DEPO-MEDROL PFIZER CANADA ULC Actual shortage 80MG Updated Report 2025-12-06 271103
MAGNESIUM SULFATE INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 500MG Updated Report 2025-12-06 271349
MYLAN-PROPAFENONE MYLAN PHARMACEUTICALS ULC Actual shortage 300MG Updated Report 2025-12-06 271408
IMITREX GLAXOSMITHKLINE INC Actual shortage 20MG Updated Report 2025-12-06 271901
MYXREDLIN BAXTER CORPORATION Actual shortage 1UNIT Updated Report 2025-12-06 272638
ADMELOG SOLOSTAR SANOFI-AVENTIS CANADA INC Resolved 100UNIT Updated Report 2025-12-06 272482
APO-ESOMEPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2025-12-05 271937
ZAMINE 28 APOTEX INC Resolved 0.03MG 3MG Updated Report 2025-12-05 270732
APO-DESVENLAFAXINE APOTEX INC Actual shortage 50MG Updated Report 2025-12-05 271859
APO-DESVENLAFAXINE APOTEX INC Actual shortage 50MG Updated Report 2025-12-05 272356
APO-OXYCODONE/ACET APOTEX INC Resolved 325MG 5MG Updated Report 2025-12-05 261617
APO-TOPIRAMATE APOTEX INC Resolved 100MG Updated Report 2025-12-05 271254
ACH-DONEPEZIL ACCORD HEALTHCARE INC Actual shortage 10MG New Report 2025-12-05 273555
TEVA-SPIRONOLACTONE TEVA CANADA LIMITED Actual shortage 25MG Updated Report 2025-12-05 269672
TEVA-SERTRALINE TEVA CANADA LIMITED Actual shortage 50MG Updated Report 2025-12-05 273277
TEVA-NAPROXEN EC TEVA CANADA LIMITED Actual shortage 500MG Updated Report 2025-12-05 259011
TEVA-OXYCOCET TEVA CANADA LIMITED Actual shortage 325MG 5MG Updated Report 2025-12-05 253150
TEVA-LENOLTEC NO. 3 TEVA CANADA LIMITED Actual shortage 15MG 30MG 300MG Updated Report 2025-12-05 273249
TEVA-PROPRANOLOL TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2025-12-05 272283
TEVA-PROPRANOLOL TEVA CANADA LIMITED Resolved 10MG Updated Report 2025-12-05 266970
TEVA-GABAPENTIN TEVA CANADA LIMITED Resolved 100MG Updated Report 2025-12-05 269229
TEVA-GABAPENTIN TEVA CANADA LIMITED Resolved 400MG Updated Report 2025-12-05 269232
NOVAMOXIN TEVA CANADA LIMITED Actual shortage 500MG Updated Report 2025-12-05 272751
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 2MG Updated Report 2025-12-05 271950
ROPIVACAINE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 2MG Updated Report 2025-12-05 268276
TARO-ACYCLOVIR TARO PHARMACEUTICALS INC Actual shortage 5% Updated Report 2025-12-05 259438
TARO-TRAMADOL ER TARO PHARMACEUTICALS INC Actual shortage 300MG New Report 2025-12-05 237266
POLYDERM OINTMENT USP TARO PHARMACEUTICALS INC Actual shortage 500UNIT 10000UNIT Updated Report 2025-12-05 267179
POLYDERM OINTMENT USP TARO PHARMACEUTICALS INC Actual shortage 500UNIT 10000UNIT Updated Report 2025-12-05 267182
TARO-PEMETREXED TARO PHARMACEUTICALS INC Actual shortage 500MG New Report 2025-12-05 267208
TARO-PEMETREXED TARO PHARMACEUTICALS INC Actual shortage 100MG New Report 2025-12-05 237242
TARO-PEMETREXED TARO PHARMACEUTICALS INC Actual shortage 1000MG New Report 2025-12-05 237239
TARO-FUSIDIC ACID TARO PHARMACEUTICALS INC Actual shortage 2% Updated Report 2025-12-05 259496
TARO-CICLOPIROX TARO PHARMACEUTICALS INC Actual shortage 8% New Report 2025-12-05 268830
TARO-BUDESONIDE TARO PHARMACEUTICALS INC Actual shortage 0.5MG Updated Report 2025-12-05 173511
TARO-BUDESONIDE TARO PHARMACEUTICALS INC Actual shortage 0.25MG New Report 2025-12-05 262079
TARO-BUDESONIDE TARO PHARMACEUTICALS INC Actual shortage 0.125MG Updated Report 2025-12-05 173505
TARO-BORTEZOMIB TARO PHARMACEUTICALS INC Actual shortage 2.5MG New Report 2025-12-05 237229
TARO-ACITRETIN TARO PHARMACEUTICALS INC Actual shortage 25MG New Report 2025-12-05 215064
TARO-ACITRETIN TARO PHARMACEUTICALS INC Actual shortage 10MG New Report 2025-12-05 215061
VESICARE ASTELLAS PHARMA CANADA INC Anticipated shortage 10MG Updated Report 2025-12-05 267787
TARO-WARFARIN TARO PHARMACEUTICALS INC Actual shortage 10MG Updated Report 2025-12-05 271600
VESICARE ASTELLAS PHARMA CANADA INC Anticipated shortage 5MG Updated Report 2025-12-05 267784
CLOTRIMADERM TOPICAL TARO PHARMACEUTICALS INC Actual shortage 1% Updated Report 2025-12-05 271663
TARO-DASATINIB TARO PHARMACEUTICALS INC Actual shortage 100MG Updated Report 2025-12-05 271667
TARO-CLINDAMYCIN TARO PHARMACEUTICALS INC Actual shortage 1% Updated Report 2025-12-05 268833
TARO-DESVENLAFAXINE TARO PHARMACEUTICALS INC Actual shortage 100MG Updated Report 2025-12-05 271670
TARO-LURASIDONE TARO PHARMACEUTICALS INC Actual shortage 60MG Updated Report 2025-12-05 268855

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 500MG Updated Report 2025-12-06 273434
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 750MG Updated Report 2025-12-06 273437
NAT-OMEPRAZOLE DR NATCO PHARMA (CANADA) INC Discontinued 20MG Updated Report 2025-12-06 273440
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 25MG Updated Report 2025-12-06 273482
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 100MG Updated Report 2025-12-06 273489
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 200MG Updated Report 2025-12-06 273496
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Discontinued 300MG Updated Report 2025-12-06 273501
NAT-DONEPEZIL NATCO PHARMA (CANADA) INC Discontinued 5MG Updated Report 2025-12-06 273383
NAT-DONEPEZIL NATCO PHARMA (CANADA) INC Discontinued 10MG Updated Report 2025-12-06 273387
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 250MG Updated Report 2025-12-06 273390
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC Discontinued 15MG Updated Report 2025-12-04 273109
TARO-LANSOPRAZOLE SUN PHARMA CANADA INC Discontinued 30MG Updated Report 2025-12-04 273112
SINGULAIR ORGANON CANADA INC. Discontinued 4MG Updated Report 2025-12-03 272220
CANCIDAS MERCK CANADA INC To be discontinued 70MG New Report 2025-12-02 273087
CANCIDAS MERCK CANADA INC To be discontinued 50MG New Report 2025-12-02 273084
SANDOZ RISPERIDONE SANDOZ CANADA INCORPORATED Discontinued 0.5MG Updated Report 2025-12-02 272923
TRUSOPT ELVIUM LIFE SCIENCES To be discontinued 2% Updated Report 2025-12-01 267941
APTIOM SUMITOMO PHARMA CANADA, INC. To be discontinued 200MG Updated Report 2025-12-01 266211
APTIOM SUMITOMO PHARMA CANADA, INC. To be discontinued 400MG Updated Report 2025-12-01 266763
APTIOM SUMITOMO PHARMA CANADA, INC. To be discontinued 600MG Updated Report 2025-12-01 266766